Dr. Thomas Joseph Gal Jr., MD

Dr. Gal practices at University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare.

Dr. Gal's NPI, 1902884182, was assigned on January 6, 2006. Dr. Gal graduated from Sidney Kimmel Medical College in 1993. Dr. Gal holds Kentucky license 40491.

Dr. Gal's primary practice is University of Kentucky Albert B. Chandler Hospital, at 800 Rose Street, Lexington, KY 40536 in Fayette County. The practice phone is (859) 257-2278.

Dr. Gal's primary practice is University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare. The medical group on file is University of Kentucky General Pediatrics.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gal practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Gal's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Gal is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Gal's licenses on file in 5 states: Kentucky, Florida, Texas, Alabama and New Mexico.

Dmand AI lists larynx and vocal cord disease among the conditions Dr. Gal treats.

CMS data shows 94 Medicare services from Dr. Gal across 3 procedure codes in 2024, all of them office visits, for 95 Medicare patients. Medicare paid $6,709 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Gal in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gal's median patient age at 69, with 31% women.

In 2024, Dr. Gal wrote 209 Medicare Part D claims for 50 patients. 88% of them were for generic drugs. CMS names the drug for 46 of them, across 2 drugs with 11 or more claims each, at $450 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Gal for performance year 2024, reported as part of a group. Dr. Gal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 40 papers to Dr. Gal, published from 2010 to 2022. 2017 was the busiest year, with 4. The most frequent topics are Carcinoma, Squamous Cell, Diagnosis, Differential and Laryngeal Neoplasms. Dr. Gal has published most often in Otolaryngol Head Neck Surg. Dr. Gal's most frequent co-authors are Douglas William Klotch, MD, Joseph Valentino, MD and Rony Aouad, MD.

Dmand AI links Dr. Gal to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Papillomavirus Infections and Oropharyngeal Neoplasms.

CMS Open Payments shows 55 general payments to Dr. Gal from 8 drug and device companies from 2016 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 34% of the total. Synthes GmbH paid the most, $23,786.

Dmand AI lists 1 award for Dr. Gal.

Dr. Gal graduated from Sidney Kimmel Medical College in 1993. Dr. Gal is a member of ACS.

Dr. Gal is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.